|
|
Volumn 5, Issue 3, 2003, Pages 261-262
|
|
Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CASE REPORT;
COMBINED IMMUNODEFICIENCY;
ETHICS;
EUROPE;
GENE THERAPY;
HUMAN;
INFANT;
PRESCHOOL CHILD;
CHILD, PRESCHOOL;
EUROPE;
GENE THERAPY;
HUMANS;
INFANT;
SEVERE COMBINED IMMUNODEFICIENCY;
|
|
EID: 0043033652
PISSN: 1099498X
EISSN: None
Source Type: Journal
DOI: 10.1002/jgm.390 Document Type: Article |
|
Times cited : (50)
|
|
References (0)
|
